Reduced blood accumulation of biotinylated monoclonal antibody A7 after the subsequent administration of avidin

Cancer Lett. 1997 Dec 9;120(2):127-34. doi: 10.1016/s0304-3835(97)00257-7.

Abstract

Clear immunoscintigraphy with radiolabeled monoclonal antibodies (MAbs) requires a high tumor tissue/blood ratio of radioactivity. In this study, we attempted to obtain a high tumor tissue/blood ratio by the active removal of radiolabeled MAb from the circulation, using the avidin-biotin system. Biotinylated 125I-labeled MAb A7 was injected intravenously into nude mice bearing a human colon cancer (WiDr) xenograft. Avidin was injected 24 h later. The tumor tissue/blood ratio of radioactivity was almost four times that of controls. These results suggest that biotinylated 125I-labeled MAb A7 and avidin are potentially useful for the rapid immunodetection of human colon cancer.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacokinetics*
  • Antigens, Neoplasm / immunology
  • Avidin / administration & dosage*
  • Avidin / pharmacology
  • Biotin / blood
  • Biotin / pharmacokinetics*
  • Colonic Neoplasms / diagnostic imaging*
  • Colonic Neoplasms / immunology
  • Humans
  • Kidney / metabolism
  • Liver / metabolism
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Radioimmunoassay
  • Radionuclide Imaging
  • Spleen / metabolism
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Avidin
  • Biotin